Atlas Trials

Omega-3 Fatty Acids in Sickle Cell Disease

Clinical trial NCT02947100 · TERMINATED

Trial details

NCT number
NCT02947100
Sponsor
Robin E. Miller
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Sickle Cell Disease
Start date
2018-01-25
Primary completion
2018-10-05
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.